Virchows Archiv

, Volume 452, Issue 6, pp 607–620 | Cite as

Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas

  • Marc-Antoine Belaud-Rotureau
  • Virginie Marietta
  • Beatrice Vergier
  • Guillaume Mainhaguiet
  • Michelle Turmo
  • Yamina Idrissi
  • Jacky Ferrer
  • Marie Beylot-Barry
  • Pierre Dubus
  • Jean-Philippe Merlio
Original Article


The World Health Organization–European Organization for Research and Treatment of Cancer has individualized three main categories among the primary cutaneous B cell lymphoma (PCBCL): leg-type primary cutaneous large B cell lymphoma (PCLBCL leg type), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous marginal zone lymphoma (PCMZL). The genetic features of 21 PCBCL cases (six PCLBCL leg type four PCFCL large cells, seven PCFCL small cells, and four PCMZL) were investigated by comparative genomic hybridization (CGH array). Fluorescent in situ hybridization (FISH) analysis was performed to confirm CGH array data and to detect lymphoma-associated gene rearrangements. p14ARF/p16INK4aCDKN2A gene quantification, methylation analysis, and immunohistochemical detection were also performed. CGH array showed a higher number of recurrent genetic imbalances in PCLBCL leg type (mean 62) than in PCFCL large cells (mean 34). PCFCL small cells and PCMZL exhibited fewer chromosomal alterations (mean 24 and 9). FISH analysis provided concordant results with CGH array data in 97% (98 of 101) assays and demonstrated a t(8;14)(q24;q32) in two of six PCLBCL leg type. Recurrent deletions in 9p21 (p14ARF/p16INK4aCDKN2A) were a constant finding in PCLBCL leg type (six of six). Conversely, PCFCL large cells exhibited recurrent 1p36 deletions (four of four) without deletion in 9p21 (zero of four). The diagnostic and prognostic impact of the p16INK4aCDKN2A gene status in PCBCL should therefore be confirmed on a larger series.


B cell Lymphoma Skin Cutaneous B cell lymphoma p16 


  1. 1.
    Belaud-Rotureau MA, Parrens M, Dubus P, Garroste JC, de Mascarel A, Merlio JP (2002) A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas. Mod Pathol 15:517–525PubMedCrossRefGoogle Scholar
  2. 2.
    Berglund M, Enblad G, Flordal E, Lui WO, Backlin C, Thunberg U, Sundstrom C, Roos G, Allander SV, Erlanson M, Rosenquist R, Larsson C, Lagercrantz S (2002) Chromosomal imbalances in diffuse large B-cell lymphoma detected by comparative genomic hybridization. Mod Pathol 15:807–816PubMedCrossRefGoogle Scholar
  3. 3.
    Child FJ, Russell-Jones R, Woolford AJ, Calonje E, Photiou A, Orchard G, Whittaker SJ (2001) Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma. Br J Dermatol 144:735–744PubMedCrossRefGoogle Scholar
  4. 4.
    Child FJ, Scarisbrick JJ, Calonje E, Orchard G, Russell-Jones R, Whittaker SJ (2002) Inactivation of tumor suppressor genes p15(INK4b) and p16(INK4a) in primary cutaneous B cell lymphoma. J Invest Dermatol 118:941–948PubMedCrossRefGoogle Scholar
  5. 5.
    de la Fouchardiere A, Gazzo S, Balme B, Chouvet B, Felman P, Coiffier B, Salles G, Callet-Bauchu E, Berger F (2006) Cytogenetic and molecular analysis of 12 cases of primary cutaneous marginal zone lymphomas. Am J Dermatopathol 28:287–292PubMedCrossRefGoogle Scholar
  6. 6.
    Dijkman R, Tensen CP, Jordanova ES, Knijnenburg J, Hoefnagel JJ, Mulder AA, Rosenberg C, Raap AK, Willemze R, Szuhai K, Vermeer MH (2006) Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma. J Clin Oncol 24:296–305PubMedCrossRefGoogle Scholar
  7. 7.
    Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB, Herman JG (2000) Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res 60:129–133PubMedGoogle Scholar
  8. 8.
    Geelen FA, Vermeer MH, Meijer CJ, Van der Putte SC, Kerkhof E, Kluin PM, Willemze R (1998) bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related. J Clin Oncol 16:2080–2085PubMedGoogle Scholar
  9. 9.
    Gellrich S, Rutz S, Golembowski S, Jacobs C, von Zimmermann M, Lorenz P, Audring H, Muche M, Sterry W, Jahn S (2001) Primary cutaneous follicle center cell lymphomas and large B cell lymphomas of the leg descend from germinal center cells. A single cell polymerase chain reaction analysis. J Invest Dermatol 117:1512–1520PubMedCrossRefGoogle Scholar
  10. 10.
    Gimenez S, Costa C, Espinet B, Sole F, Pujol RM, Puigdecanet E, Garcia-Moreno P, Sanchez J, Gallardo F, Estrach T, Garcia-Muret P, Romagosa V, Serrano S, Servitje O (2005) Comparative genomic hybridization analysis of cutaneous large B-cell lymphomas. Exp Dermatol 14:883–890PubMedCrossRefGoogle Scholar
  11. 11.
    Grange F, Bekkenk MW, Wechsler J, Meijer CJ, Cerroni L, Bernengo M, Bosq J, Hedelin G, Fink Puches R, van Vloten WA, Joly P, Bagot M, Willemze R (2001) Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study. J Clin Oncol 19:3602–3610PubMedGoogle Scholar
  12. 12.
    Grange F, Petrella T, Beylot-Barry M, Joly P, D’Incan M, Delaunay M, Machet L, Avril MF, Dalac S, Bernard P, Carlotti A, Esteve E, Vergier B, Dechelotte P, Cassagnau E, Courville P, Saiag P, Laroche L, Bagot M, Wechsler J (2004) Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas. Blood 103:3662–3668PubMedCrossRefGoogle Scholar
  13. 13.
    Hallermann C, Kaune KM, Gesk S, Martin-Subero JI, Gunawan B, Griesinger F, Vermeer MH, Santucci M, Pimpinelli N, Willemze R, Siebert R, Neumann C (2004) Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas. J Invest Dermatol 123:213–219PubMedCrossRefGoogle Scholar
  14. 14.
    Hallermann C, Kaune KM, Siebert R, Vermeer MH, Tensen CP, Willemze R, Gunawan B, Bertsch HP, Neumann C (2004) Chromosomal aberration patterns differ in subtypes of primary cutaneous B cell lymphomas. J Invest Dermatol 122:1495–1502PubMedCrossRefGoogle Scholar
  15. 15.
    Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting—Airlie House, Virginia, November 1997. J Clin Oncol 17:3835–3849PubMedGoogle Scholar
  16. 16.
    Hoefnagel JJ, Dijkman R, Basso K, Jansen PM, Hallermann C, Willemze R, Tensen CP, Vermeer MH (2005) Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. Blood 105:3671–3678PubMedCrossRefGoogle Scholar
  17. 17.
    Hoefnagel JJ, Mulder MM, Dreef E, Jansen PM, Pals ST, Meijer CJ, Willemze R, Vermeer MH (2006) Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma. Mod Pathol 19:1270–1276PubMedCrossRefGoogle Scholar
  18. 18.
    Hostein I, Pelmus M, Aurias A, Pedeutour F, Mathoulin-Pelissier S, Coindre JM (2004) Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas. J Pathol 202:95–102PubMedCrossRefGoogle Scholar
  19. 19.
    Hsi ED, Mirza I, Gascoyne RD (2002) Absence of t(14,18) chromosomal translocation in primary cutaneous B- cell lymphoma. Br J Dermatol 146:1110–1111 discussion 1111–1112PubMedCrossRefGoogle Scholar
  20. 20.
    Kodama K, Massone C, Chott A, Metze D, Kerl H, Cerroni L (2005) Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients. Blood 106:2491–2497PubMedCrossRefGoogle Scholar
  21. 21.
    Labuhn M, Jones G, Speel EJ, Maier D, Zweifel C, Gratzl O, Van Meir EG, Hegi ME, Merlo A (2001) Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas. Oncogene 20:1103–1109PubMedCrossRefGoogle Scholar
  22. 22.
    Lehmann U, Hasemeier B, Lilischkis R, Kreipe H (2001) Quantitative analysis of promoter hypermethylation in laser-microdissected archival specimens. Lab Invest 81:635–638PubMedGoogle Scholar
  23. 23.
    Mao X, Lillington D, Child F, Russell-Jones R, Young B, Whittaker S (2002) Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: identification of common genomic alterations in disease pathogenesis. Genes Chromosomes Cancer 35:144–155PubMedCrossRefGoogle Scholar
  24. 24.
    Mao X, Orchard G, Lillington DM, Child FJ, Vonderheid EC, Nowell PC, Bagot M, Bensussan A, Russell-Jones R, Young BD, Whittaker SJ (2004) BCL2 and JUNB abnormalities in primary cutaneous lymphomas. Br J Dermatol 151:546–556PubMedCrossRefGoogle Scholar
  25. 25.
    Monni O, Joensuu H, Franssila K, Klefstrom J, Alitalo K, Knuutila S (1997) BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood 90:1168–1174PubMedGoogle Scholar
  26. 26.
    Sanchez-Aguilera A, Delgado J, Camacho FI, Sanchez-Beato M, Sanchez L, Montalban C, Fresno MF, Martin C, Piris MA, Garcia JF (2004) Silencing of the p18INK4c gene by promoter hypermethylation in Reed-Sternberg cells in Hodgkin lymphomas. Blood 103:2351–2357PubMedCrossRefGoogle Scholar
  27. 27.
    Schreuder MI, Hoefnagel JJ, Jansen PM, van Krieken JH, Willemze R, Hebeda KM (2005) FISH analysis of MALT lymphoma-specific translocations and aneuploidy in primary cutaneous marginal zone lymphoma. J Pathol 205:302–310PubMedCrossRefGoogle Scholar
  28. 28.
    Senff NJ, Hoefnagel JJ, Jansen PM, Vermeer MH, van Baarlen J, Blokx WA, Canninga-van Dijk MR, Geerts ML, Hebeda KM, Kluin PM, Lam KH, Meijer CJ, Willemze R (2007) Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO–EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol 25:1581–1587PubMedCrossRefGoogle Scholar
  29. 29.
    Streubel B, Scheucher B, Valencak J, Huber D, Petzelbauer P, Trautinger F, Weihsengruber F, Mannhalter C, Cerroni L, Chott A (2006) Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas. Am J Surg Pathol 30:529–536PubMedCrossRefGoogle Scholar
  30. 30.
    Vergier B, Belaud-Rotureau MA, Benassy MN, Beylot-Barry M, Dubus P, Delaunay M, Garroste JC, Taine L, Merlio JP (2004) Neoplastic cells do not carry bcl2-JH rearrangements detected in a subset of primary cutaneous follicle center B-cell lymphomas. Am J Surg Pathol 28:748–755PubMedCrossRefGoogle Scholar
  31. 31.
    Wiesner T, Streubel B, Huber D, Kerl H, Chott A, Cerroni L (2005) Genetic aberrations in primary cutaneous large B-cell lymphoma: a fluorescence in situ hybridization study of 25 cases. Am J Surg Pathol 29:666–673PubMedCrossRefGoogle Scholar
  32. 32.
    Willemze R (2006) Primary cutaneous B-cell lymphoma: classification and treatment. Curr Opin Oncol 18:425–431PubMedCrossRefGoogle Scholar
  33. 33.
    Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ (2005) WHO–EORTC classification for cutaneous lymphomas. Blood 105:3768–3785PubMedCrossRefGoogle Scholar
  34. 34.
    Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJ (1997) EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90:354–371PubMedGoogle Scholar
  35. 35.
    Wongchaowart NT, Kim B, Hsi ED, Swerdlow SH, Tubbs RR, Cook JR (2006) t(14;18)(q32;q21) involving IGH and MALT1 is uncommon in cutaneous MALT lymphomas and primary cutaneous diffuse large B-cell lymphomas. J Cutan Pathol 33:286–292PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Marc-Antoine Belaud-Rotureau
    • 1
    • 2
  • Virginie Marietta
    • 1
  • Beatrice Vergier
    • 1
    • 2
  • Guillaume Mainhaguiet
    • 1
  • Michelle Turmo
    • 1
  • Yamina Idrissi
    • 1
  • Jacky Ferrer
    • 1
    • 2
  • Marie Beylot-Barry
    • 1
    • 3
  • Pierre Dubus
    • 1
    • 2
  • Jean-Philippe Merlio
    • 1
    • 2
  1. 1.EA 2406 Histologie et Pathologie Moléculaire des TumeursUniversité Victor SegalenBordeaux CedexFrance
  2. 2.Service d’Anatomie et Cytologie PathologiquesHôpital du Haut-LévêquePessac CedexFrance
  3. 3.Service de DermatologieHôpital du Haut-LévêquePessac CedexFrance

Personalised recommendations